Lv5
980 积分 2026-06-24 加入
Schizophrenia
2天前
已完结
FDA approves first schizophrenia drug with new mechanism of action since 1950s
13天前
已完结
Long-term efficacy, safety, and tolerability of xanomeline and trospium chloride in schizophrenia: A 52-week, open-label trial (EMERGENT-5)
1个月前
已完结
Long-Term Safety and Efficacy of Xanomeline and Trospium Chloride in Schizophrenia: A 52-Week Open-Label Extension Trial
1个月前
已完结
Long-Term Safety and Efficacy of Xanomeline and Trospium Chloride in Schizophrenia: A 52-Week Open-Label Extension Trial
1个月前
已完结
Pharmacological interventions for antipsychotic-related sialorrhea: a systematic review and network meta-analysis of randomized trials
1个月前
已完结
Absolute neutrophil count and adverse drug reaction monitoring during clozapine treatment: consensus guidelines from a global Delphi panel
1个月前
已完结
皖公网安备34019202002308
